In less than 10 years, the prognosis of chronic myeloid leukaemia has changed from that of
a fatal disease to a disorder amenable simply to lifelong oral medication and compatible …

The graft-versus-tumour effect seen after allogeneic (genetically different) haematopoietic
cell transplantation for human malignancies represents the clearest example of the power of …

Defining conditioning regimen intensity has become a critical issue for the hemopoietic stem
cell transplant (HSCT) community. In the present report we propose to define conditioning …

During the 2006 BMT Tandem Meetings, a workshop was convened by the Center for
International Blood and Marrow Transplant Research (CIBMTR) to discuss conditioning …

Toxicities have limited the use of allogeneic hematopoietic cell transplantation (HCT) to
younger, medically fit patients. In a canine HCT model, a combination of postgrafting …

Because information on management and outcome of AML relapse after allogeneic
hematopoietic stem cell transplantation (HSCT) with reduced intensity conditioning (RIC) is …

Background Since allogeneic stem-cell transplantation can induce curative graft-versus-
leukemia reactions in patients with hematologic cancers, we sought to induce analogous …

The purpose of this prospective multicenter phase 2 trial was to investigate the long-term
outcome of reduced-intensity conditioning allogeneic stem cell transplantation (alloSCT) in …

Chronic lymphocytic leukemia (CLL) is associated with a variety of immunologic
disturbances. Hypogammaglobulinemia and autoimmune phenomena are both often …

It is unknown whether the severity, timing, and quality of graft-versus-host disease (GVHD)
may be different after nonmyeloablative as compared with myeloablative hematopoietic …